CLAX-20

Description

Chemical Identity

CLAX-20 is a proprietary research blend formulated for laboratory investigation of multi-target metabolic and body composition modulation. As a proprietary formulation, the exact composition and molecular specifications are specific to the manufacturer’s formulation protocol. CLAX-20 is designed for researchers studying combined-mechanism approaches to metabolic function, energy balance, and body composition in preclinical models.

CLAX-20 is a proprietary designation unique to Prescott Bio Canada.

Research Overview

CLAX-20 has been developed as a multi-component research compound for investigators studying combined-action approaches to metabolic modulation. Proprietary blend formulations allow researchers to investigate potential synergistic or additive effects of multiple active components administered as a single reconstituted preparation, reducing variability associated with separate reconstitution and administration of individual compounds.

Key research areas relevant to multi-target metabolic blends include:

• Combined-Mechanism Metabolic Research: Multi-component formulations targeting complementary metabolic pathways have gained increasing attention in preclinical research. By engaging multiple receptor systems or enzymatic targets simultaneously, blend formulations may produce effects that differ from individual component administration, enabling researchers to study pharmacological interactions and pathway convergence.
• Body Composition Studies: Research into body composition modulation has demonstrated that compounds targeting different aspects of energy balance — appetite regulation, energy expenditure, lipid metabolism, and lean mass preservation — may produce distinct compositional outcomes when combined compared to monotherapy approaches.
• Formulation and Stability Research: Proprietary blends present unique formulation challenges including component compatibility, co-lyophilization stability, and reconstitution behavior. CLAX-20 has been formulated to maintain component integrity through the lyophilization process.

As a proprietary blend, the evidence base for CLAX-20 specifically is limited. Researchers should evaluate individual active components in the published literature to inform experimental design.

Specifications

All CLAX-20 supplied by Prescott Bio Canada is manufactured to research-grade standards.

Each vial is accompanied by a Certificate of Analysis (COA) documenting quality control testing results.

Research Applications

CLAX-20 is supplied exclusively for in vitro and in vivo laboratory research. Potential experimental applications include:

• Investigation of multi-target metabolic modulation approaches in preclinical models
• Study of combined-mechanism effects on body composition, energy balance, and metabolic parameters
• Examination of formulation compatibility and co-lyophilization stability for multi-peptide preparations
• Research into synergistic or additive pharmacological interactions between complementary metabolic compounds

Researchers should consult the product datasheet and relevant primary literature before designing experiments with CLAX-20.

Storage and Handling

Lyophilized powder: Store at -20°C in the original sealed vial, protected from light and moisture. Under these conditions, CLAX-20 maintains stability for up to 24 months.

Reconstituted solution: Reconstitute with bacteriostatic water or sterile water to the desired concentration. Store reconstituted CLAX-20 at 2-8°C and use within 30 days. Avoid repeated freeze-thaw cycles.

Handling precautions: This product is intended for research use only (RUO). Not for human or veterinary diagnostic or therapeutic use. Handle using standard laboratory safety practices including appropriate PPE.